Why Purdue’s bankruptcy was “long, painful, frustrating”

Purdue Pharma filed for bankruptcy in 2019 but it took until last month for a bankruptcy judge to approve Purdue’s $7.4billion settlement plan. “I’m happy there’s a settlement, but it’s a hollow victory,” one litigant said. Purdue’s assets will be transferred to a new company, Knoa Pharma, which aims to profit from drug treatments and overdoses.